Published in Nephron on January 01, 1993
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol (2008) 1.64
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest (2004) 1.28
Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol (1996) 1.00
Pathological role of tonsillar B cells in IgA nephropathy. Clin Dev Immunol (2011) 0.90
Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol (1995) 0.89
Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy. Clin Exp Immunol (2006) 0.77
Update on immunoglobulin A nephropathy, Part I: Pathophysiology. World J Nephrol (2015) 0.76
IgA nephropathy enigma. Clin Immunol (2016) 0.75
Accidental dural puncture and post dural puncture headache in obstetric anaesthesia: presentation and management: a 23-year survey in a district general hospital. Anaesthesia (2008) 3.48
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer (2008) 2.09
'Ventilating in recovery'--the way forward: intensive therapy or postoperative critical care? Br J Anaesth (2002) 2.04
Isolated microscopic haematuria in the genitourinary clinic: the value of renal biopsy. Int J STD AIDS (1997) 2.02
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int (2001) 1.99
Treatment of IgA nephropathy. Kidney Int (2006) 1.98
Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol (2002) 1.95
Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med (1992) 1.79
Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer (2007) 1.75
VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis (2006) 1.71
Glomerular disease as a cause of isolated microscopic haematuria. Q J Med (1994) 1.70
In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol (1987) 1.70
High incidence of end-stage renal disease in Indo-Asians in the UK. QJM (1995) 1.68
Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol (1995) 1.66
Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer (2004) 1.63
Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res (1990) 1.57
High incidence of minimal change nephrotic syndrome in Asians. Arch Dis Child (1985) 1.51
Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am J Kidney Dis (1994) 1.50
The effect of epidural blockade on gastric intramucosal pH in the peri-operative period. Anaesthesia (1996) 1.45
Parathyroidectomy in chronic renal failure: comparison of three operative strategies. J R Coll Surg Edinb (1996) 1.44
Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. Nephrol Dial Transplant (1993) 1.43
Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol Dial Transplant (1992) 1.43
The third World Kidney Day: looking back and thinking forward. Clin Nephrol (2008) 1.39
Glucose polymer for ultrafiltration failure in CAPD. Lancet (1993) 1.38
Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment. Br J Haematol (1991) 1.38
A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int (2000) 1.35
IgA nephropathy: recent developments. J Am Soc Nephrol (2000) 1.31
Diabetic renal disease: differences between Asian and white patients. Br Med J (Clin Res Ed) (1986) 1.29
The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo. J Physiol (2006) 1.24
Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant (1997) 1.21
Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant (1998) 1.19
ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity. Microcirculation (2002) 1.18
Randomized clinical trial of laparoscopic versus open donor nephrectomy. Br J Surg (2010) 1.14
Physical exercise in patients with severe kidney disease. Nephron Clin Pract (2010) 1.12
Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxin. Arch Intern Med (1979) 1.10
High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis (1991) 1.10
VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br J Cancer (2009) 1.07
IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. Am J Kidney Dis (2000) 1.06
Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol (1999) 1.06
RCPE UK consensus conference statement: Management of acute kidney injury: the role of fluids, e-alerts and biomarkers. J R Coll Physicians Edinb (2013) 1.02
Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol (1996) 1.00
Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura. Clin Exp Immunol (1994) 1.00
Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond (1990) 0.99
Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin Sci (Lond) (1999) 0.99
Glomerular IgA deposition in liver disease. Nephrol Dial Transplant (1999) 0.99
Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int (1986) 0.98
Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. N Engl J Med (1984) 0.98
VEGF-C promotes survival in podocytes. Am J Physiol Renal Physiol (2006) 0.97
Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM (2005) 0.96
Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol (1999) 0.95
B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. Kidney Int (2008) 0.95
Specific cytogenetic abnormalities and k-ras mutation in two new human colorectal-adenoma-derived cell lines. Int J Cancer (1992) 0.95
Gm allotypes in membranous nephropathy. N Engl J Med (1983) 0.94
Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int (1994) 0.93
The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol (1992) 0.93
Primary tuberculosis of the esophagus. Am J Gastroenterol (1984) 0.92
Is chronic renal transplant rejection a non-immunological phenomenon? Lancet (1986) 0.92
Asymptomatic microscopical haematuria. Br Med J (Clin Res Ed) (1986) 0.91
The non-peptidyl fungal metabolite L-783,281 activates TRK neurotrophin receptors. J Neurochem (2001) 0.90
Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis (1998) 0.90
Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol (1995) 0.89
Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am J Kidney Dis (1999) 0.89
Outcome of acute renal failure following surgical repair of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2000) 0.89
Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy. Clin Exp Immunol (1992) 0.88
Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugs. Diabetologia (2007) 0.88
Renal failure due to cholesterol embolisation. Postgrad Med J (1995) 0.87
Laparoscopic donor nephrectomy yields kidneys with structure and function equivalent to those retrieved by open surgery. Transplant Proc (2005) 0.86
Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier. Am J Kidney Dis (1997) 0.86
Simultaneous in situ hybridisation of native mRNA and immunoglobulin detection by conventional immunofluorescence in paraffin wax embedded sections. J Clin Pathol (1992) 0.86
Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J Intern Med (1992) 0.85
Rate of decline in renal function in Indo-Asians and Whites with diabetic nephropathy. Diabet Med (1998) 0.85
Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. Clin Immunol Immunopathol (1993) 0.85
Iga nephropathy, antineutrophil cytoplasmic antibodies and crescentic glomerulonephritis in a patient with the Hermansky-Pudlak syndrome. Am J Nephrol (2001) 0.85
Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure. Nephrol Dial Transplant (1992) 0.85
Recurrent acute renal failure with interstitial nephritis due to D-penicillamine. Ren Fail (1987) 0.85
The new Oxford Clinico-Pathological Classification of IgA nephropathy. Prilozi (2010) 0.84
Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity. Clin Sci (Lond) (1990) 0.84
Expression of the mucosal gamma delta T cell receptor V region repertoire in patients with IgA nephropathy. Kidney Int (1997) 0.83
Identification of a novel Fcalpha receptor expressed by human mesangial cells. Kidney Int (2000) 0.83
Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertility. Reproduction (2012) 0.83
A quantitative study comparing adjustment and acceptance of illness in adults on renal replacement therapy. ANNA J (1999) 0.83
High risk acute renal failure. Q J Med (1986) 0.83
In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy. Exp Nephrol (1994) 0.82
A comparative study of digoxigenin, 2,4-dinitrophenyl, and alkaline phosphatase as deoxyoligonucleotide labels in non-radioisotopic in situ hybridisation. J Clin Pathol (1997) 0.82
The effect of nifedipine on renal function in normotensive cyclosporin-A-treated renal allograft recipients. Nephrol Dial Transplant (1990) 0.82
Listeria monocytogenes peritonitis complicating CAPD. Perit Dial Int (1989) 0.82
Increasing frequency of adult IgA nephropathy in the UK? Lancet (1987) 0.82
A consecutive series of 70 laparoscopic donor nephrectomies demonstrates the safety of this new operation. Transplant Proc (2005) 0.82
Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy. Exp Nephrol (1994) 0.81
Acute renal failure associated with haematological malignancies: a review of 10 years experience. Eur J Haematol (1991) 0.81
Elective conversion from cyclosporine to azathioprine: long-term follow-up. Transplant Proc (1987) 0.81